Source:http://linkedlifedata.com/resource/pubmed/id/19713988
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2009-8-28
|
pubmed:abstractText |
Clostridium difficile infection (CDI) has emerged as a problem of epidemic proportions. Previous exposure to broad-spectrum antibiotics remains the most important predisposing factor for the disease. However, PPIs are increasingly being overprescribed and recent research has, therefore, focused on the association between PPI therapy and CDI. While the data remain observational, increasing evidence exists for at least a modest association between PPI use and CDI.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1759-5053
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
555-7
|
pubmed:meshHeading |
pubmed-meshheading:19713988-Anti-Bacterial Agents,
pubmed-meshheading:19713988-Clostridium difficile,
pubmed-meshheading:19713988-Enterocolitis, Pseudomembranous,
pubmed-meshheading:19713988-Esophagitis,
pubmed-meshheading:19713988-Gastric Acid,
pubmed-meshheading:19713988-Humans,
pubmed-meshheading:19713988-Peptic Ulcer,
pubmed-meshheading:19713988-Proton Pump Inhibitors,
pubmed-meshheading:19713988-Risk Factors
|
pubmed:year |
2009
|
pubmed:articleTitle |
Does PPI therapy predispose to Clostridium difficile infection?
|
pubmed:affiliation |
Louisiana State University Health Sciences Center and Overton Brooks VA Medical Center, Shreveport, LA, USA.
|
pubmed:publicationType |
Journal Article
|